US Codex
Bill
Notes

H.R. 8646 — what changed

Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

From Reported in House to Engrossed in House. 1 section amended and 3 added between Reported in House and Engrossed in House.

Sec. 754

changed Section 9(a)(2) of the Richard B. Russell National School Lunch Act (42 U.S.C. 1758(a)(2)) is amended —amended—

(1)
in subparagraph (A), in the matter preceding clause (i), by striking “Act—” and inserting “Act and breakfasts served by schools participating in the school breakfast program under section 4 of the Child Nutrition Act of 1966 (42 U.S.C. 1773)—”;
(2)
in subparagraph (C), by inserting “or the school breakfast program under section 4 of the Child Nutrition Act of 1966 (42 U.S.C. 1773)” after “Act”; and
(3)
in subparagraph (D), by striking “section 210.10” and inserting “sections 210.10 and 220.8”.

Sec. 781

added

added None of the funds made available by this Act may be used by the Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, or Center for Devices and Radiological Health within the Food and Drug Administration to issue or finalize guidance recommending or requiring testing in dogs.

Sec. 782

added

added None of the funds made available by this Act may be used by the National Institute of Food and Agriculture within the Department of Agriculture to conduct or fund research involving a dog or cat (as such terms are defined in section 1.1 of title 9, Code of Federal Regulations) that is classified in pain category D or E, as defined by the Department of Agriculture.

Sec. 783

added

added None of the funds made available by this Act may be used in contravention of section 506C(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356c(g)) with respect to the review of an application or supplement, or the inspection or reinspection of an establishment, that could help mitigate or prevent a shortage of a sterile injectable drug used in cancer treatment and listed as being in shortage by the Food and Drug Administration.